79
Participants
Start Date
December 13, 2005
Primary Completion Date
March 11, 2018
Study Completion Date
March 11, 2018
rituximab
Given IV
bortezomib
Given IV
cyclophosphamide
Given IV
prednisone
Given orally
Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York
Memorial Sloan-Kettering Cancer Center, New York
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack
Winship Cancer Institute of Emory University, Atlanta
Memorial Sloan-Kettering at Basking Ridge, Basking Ridge
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick
Memorial Sloan-Kettering at Mercy Medical Center, Rockville Centre
Memoral Sloan Kettering Cancer Center@Phelps, Sleepy Hollow
National Cancer Institute (NCI)
NIH
Rutgers Cancer Institute of New Jersey
OTHER
Columbia University
OTHER
Emory University
OTHER
Memorial Sloan Kettering Cancer Center
OTHER